Browse > Article
http://dx.doi.org/10.14348/molcells.2014.2353

NF-κB in Cellular Senescence and Cancer Treatment  

Jing, Hua (MKFZ, Charite - Universitatsmedizin Berlin and Max-Delbruck-Centrum for Molecular Medicine)
Lee, Soyoung (MKFZ, Charite - Universitatsmedizin Berlin and Max-Delbruck-Centrum for Molecular Medicine)
Abstract
The NF-${\kappa}B$ pathway transcriptionally controls a large set of target genes that play important roles in cell survival, inflammation, and immune responses. While many studies showed anti-tumorigenic and pro-survival role of NF-${\kappa}B$ in cancer cells, recent findings postulate that NF-${\kappa}B$ participates in a senescence-associated cytokine response, thereby suggesting a tumor restraining role of NF-${\kappa}B$. In this review, we discuss implications of the NF-${\kappa}B$ signaling pathway in cancer. Particularly, we emphasize the connection of NF-${\kappa}B$ with cellular senescence as a response to chemotherapy, and furthermore, present examples how distinct oncogenic network contexts surrounding NF-${\kappa}B$ produce fundamentally different treatment outcomes in aggressive B-cell lymphomas as an example.
Keywords
cancer; chemotherapy; NF-${\kappa}B$; senescence;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Davis, R.E., Brown, K.D., Siebenlist, U., and Staudt, L.M. (2001). Constitutive nuclear factor kappa B activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194, 1861-1874.   DOI
2 Huang, J.Z., Sanger, W.G., Greiner, T.C., Staudt, L.M., Weisenburger, D.D., Pickering, D.L., Lynch, J.C., Armitage, J.O., Warnke, R.A., Alizadeh, A.A., et al. (2002). The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 99, 2285-2290.   DOI   ScienceOn
3 Inokuchi, S., Aoyama, T., Miura, K., Osterreicher, C.H., Kodama, Y., Miyai, K., Akira, S., Brenner, D.A., and Seki, E. (2010). Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc. Natl. Acad. Sci. USA 107, 844-849.   DOI   ScienceOn
4 Iqbal, J., Sanger, W.G., Horsman, D.E., Rosenwald, A., Pickering, D.L., Dave, B., Dave, S., Xiao, L., Cao, K., Zhu, Q., et al. (2004). BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am. J. Pathol. 165, 159-166.   DOI   ScienceOn
5 Kaltschmidt, B., Kaltschmidt, C., Hofmann, T.G., Hehner, S.P., Droge, W., and Schmitz, M.L. (2000). The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur. J. Biochem. 267, 3828-3835.   DOI   ScienceOn
6 Coppe, J.P., Patil, C.K., Rodier, F., Sun, Y., Munoz, D.P., Goldstein, J., Nelson, P.S., Desprez, P.Y., and Campisi, J. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868.
7 Coppe, J.P., Desprez, P.Y., Krtolica, A., and Campisi, J. (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118.   DOI   ScienceOn
8 Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K., and Siebenlist, U. (1992). The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-$\kappa{B}$-mediated inhibition. Nature 359, 339-342.   DOI   ScienceOn
9 Guttridge, D.C., Albanese, C., Reuther, J.Y., Pestell, R.G., and Baldwin, A.S. Jr. (1999). NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19, 5785-5799.   DOI
10 Grivennikov, S., Greten, F.R., and Karin, M. (2010). Immunity, inflammation, and cancer. Cell 140, 883-899.   DOI   ScienceOn
11 Hayden, M.S., and Ghosh, S. (2004). Signaling to NF-kappaB. Genes Dev. 18, 2195-2224.   DOI   ScienceOn
12 Hayden, M.S., and Ghosh, S. (2008). Shared principles in NF-kappaB signaling. Cell 132, 344-362.   DOI   ScienceOn
13 Heyninck, K., and Beyaert, R. (2005). A20 inhibits NF-$\kappa{B}$activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 30, 1-4.   DOI   ScienceOn
14 Lim, K.H., Yang, Y., and Staudt, L.M. (2012). Pathogenetic importance and therapeutic implications of NF-$\kappa{B}$in lymphoid malignancies. Immunol. Rev. 246, 359-378.   DOI   ScienceOn
15 Lam, L.T., Davis, R.E., Pierce, J., Hepperle, M., Xu, Y., Hottelet, M., Nong, Y., Wen, D., Adams, J., Dang, L., et al. (2005). Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin. Cancer Res. 11, 28-40.
16 Lenz, G., Davis, R.E., Ngo, V.N., Lam, L., George, T.C., Wright, G. W., Dave, S.S., Zhao, H., Xu, W., Rosenwald, A., et al. (2008a). Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676-1679.   DOI   ScienceOn
17 Lenz, G., Wright, G., Dave, S.S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008b). Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med. 359, 2313-232.   DOI   ScienceOn
18 Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., and Pasparakis, M. (2007). Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11, 119-132.   DOI   ScienceOn
19 Martin, A.G., Trama, J., Crighton, D., Ryan, K.M., and Fearnhead, H.O. (2009). Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B. Aging 1, 335-349.   DOI
20 Maeda, S., Kamata, H., Luo, J.L., Leffert, H., and Karin, M. (2005). IKK couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977-990.   DOI   ScienceOn
21 Compagno, M., Lim, W.K., Grunn, A., Nandula, S.V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A., et al. (2009). Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459, 717-721.   DOI   ScienceOn
22 Keats, J.J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.J., Van Wier, S., Tiedemann, R., Shi, C.X., Sebag, M., et al. (2007). Promiscuous mutations activate the noncanonical NF-$\kappa{B}$pathway in multiple myeloma. Cancer Cell 12, 131-144.   DOI   ScienceOn
23 Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., Wirth, T., and Schwaninger, M. (1999). NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5, 554-559.   DOI   ScienceOn
24 Seitz, C.S., Lin, Q., Deng, H., and Khavari, P.A. (1998). Alterations in NF-$\kappa{B}$function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-$\kappa{B}$. Proc. Natl. Acad. Sci. USA 95, 2307-2312.   DOI
25 Keller, U., Huber, J., Nilsson, J.A., Fallahi, M., Hall, M.A., Peschel, C., and Cleveland, J.L. (2010). Myc suppression of Nfkb2 accelerates lymphomagenesis. BMC Cancer 10, 348.   DOI   ScienceOn
26 Kortlever, R.M., Higgins, P.J., and Bernards, R. (2006). Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol. 8, 877-884.   DOI
27 Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., et al. (2002). The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937-1947.   DOI   ScienceOn
28 Kuilman, T., and Peeper, D.S. (2009). Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 9, 81-94.   DOI   ScienceOn
29 Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., van Doorn, R., Desmet, C.J., Aarden, L.A., Mooi, W.J., and Peeper, D.S. (2008). Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031.   DOI   ScienceOn
30 Kuilman, T., Michaloglou, C., Mooi, W.J., and Peeper, D.S. (2010). The essence of senescence. Genes Dev. 24, 2463-2479.   DOI   ScienceOn
31 Prasad, S., Ravindran, J., and Aggarwal, B.B. (2010). NF-kappaB and cancer: how intimate is this relationship. Mol. Cell. Biochem. 336, 25-37.   DOI
32 Reimann, M., Lee, S., Loddenkemper, C., Dorr, J.R., Tabor, V., Aichele, P., Stein, H., Dorken, B., Jenuwein, T., and Schmitt, C. A. (2010). Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. Cancer Cell. 17, 262-272.   DOI   ScienceOn
33 Rovillain, E., Mansfield, L., Caetano, C., Alvarez-Fernandez, M., Caballero, O.L., Medema, R.H., Hummerich, H., and Jat, P.S. (2011). Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 30, 2356-2366.   DOI   ScienceOn
34 Ryan, K.M., Ernst, M.K., Rice, N.R., and Vousden, K.H. (2000). Role of NF-kappaB in p53-mediated programmed cell death. Nature 404, 892-897.   DOI   ScienceOn
35 Schmitt, C.A. (2007). Cellular senescence and cancer treatment. Biochim. Biophys. Acta 1775, 5-20.
36 Yang, J., Splittgerber, R., Yull, F.E., Kantrow, S., Ayers, G.D., Karin, M., and Richmond, A. (2010). Conditional ablation of Ikk$\beta$ inhibits melanoma tumor development in mice. J. Clin. Invest. 120, 2563-2574.   DOI   ScienceOn
37 Schmitt, C.A., Fridman, J.S., Yang, M., Lee, S., Baranov, E., Hoffman, R.M., and Lowe, S.W. (2002). A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335-346.   DOI   ScienceOn
38 Sheehy, A.M., and Schlissel, M.S. (1999). Overexpression of RelA causes G1 arrest and apoptosis in a Pro-B cell line. J. Biol. Chem. 274, 8708-8716.   DOI   ScienceOn
39 Yamamoto, K., Arakawa, T., Ueda, N., and Yamamoto, S. (1995). Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270, 31315-31320.   DOI
40 Sen, R., and Baltimore, D. (1986). Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705-716.   DOI   ScienceOn
41 Neri, A., Chang, C.C., Lombardi, L., Salina, M., Corradini, P., Maiolo, AT., Chaganti, R.S., and Dalla-Favera, R. (1991). B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-$\kappa{B}$p50. Cell 67, 1075-1087.   DOI   ScienceOn
42 Ngo, V.N., Young, R.M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011). Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115-119.   DOI   ScienceOn
43 Perkins, N.D. (2007). Integrating cell-signalling pathways with NFkappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62.   DOI   ScienceOn
44 te Poele, R.H., Okorokov, A.L., Jardine, L., Cummings, J., and Joel, S.P. (2002). DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62, 1876-1883.
45 Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Baldwin, A.S. Jr. (1998). NF-$\kappa{B}$antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.   DOI   ScienceOn
46 Sun, L., Deng, L., Ea, C.K., Xia, Z.P., and Chen, Z.J. (2004). The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301.   DOI   ScienceOn
47 Tamatani, M., Che, Y.H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., Mizuno, T., and Tohyama, M. (1999). Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274, 8531-8538.   DOI   ScienceOn
48 Tu, S., Bhagat, G., Cui, G., Takaishi, S., Kurt-Jones, E.A., Rickman, B., Betz, K.S., Penz-Oesterreicher, M., Bjorkdahl, O., Fox, J.G., et al. (2008). Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14, 408-419.   DOI   ScienceOn
49 Wertz, I.E., O'Rourke, K.M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D.L., et al. (2004). De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-$\kappa{B}$signalling. Nature 430, 694-699.   DOI   ScienceOn
50 Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., and Lowe, S.W. (2007). Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656-660.   DOI   ScienceOn
51 Chang, B.D., Broude, E.V., Dokmanovic, M., Zhu, H., Ruth, A., Xuan, Y., Kandel, ES., Lausch, E., Christov, K., and Roninson, I.B. (1999). A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59, 3761-3767.
52 Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A.H., Schlegelberger, B., Stein, H., Dorken, B., Jenuwein, T., and Schmitt, C.A. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660-665.   DOI   ScienceOn
53 Calado, D.P., Zhang, B., Srinivasan, L., Sasaki, Y., Seagal, J., Unitt, C., Rodig, S., Kutok, J., Tarakhovsky, A., Schmidt-Supprian, M., et al. (2010). Constitutive canonical NF-$\kappa{B}$activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. Cancer Cell 18, 580-589.   DOI   ScienceOn
54 Catz, S.D., and Johnson, J.L. (2001). Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20, 7342-7351.   DOI   ScienceOn
55 Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., and Dixit, V.M. (2004). Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427, 167-171.   DOI   ScienceOn
56 Staudt, L.M. (2010). Oncogenic activation of NF-$\kappa{B}$. Cold Spring Harb Perspect Biol. 2, a000109.
57 Acosta, J.C., O'Loghlen, A., Banito, A., Guijarro, M.V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008). Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence. Cell 133, 1006-1018.   DOI   ScienceOn
58 Stehlik, C., de Martin. R., Kumabashiri, I., Schmid, J.A., Binder, B.R., and Lipp, J. (1998). Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188, 211-216.   DOI   ScienceOn
59 Arkan, M.C., and Greten, F.R. (2011). IKK- and NF-$\kappa{B}$-mediated functions in carcinogenesis. Curr. Top. Microbiol. Immunol. 349, 159-169.
60 Annunziata, C.M., Davis, R.E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007). Frequent engagement of the classical and alternative NF-$\kappa{B}$pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12, 115-130.   DOI   ScienceOn
61 Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511.   DOI   ScienceOn
62 Baldwin, A.S. (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107, 241-246.   DOI   ScienceOn
63 Basseres, D.S., and Baldwin, A.S. (2006). Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25, 6817-6830.   DOI   ScienceOn
64 Basseres, D.S., Ebbs, A., Levantini, E., and Baldwin, A.S. (2010). Requirement of the NF-$\kappa{B}$subunit p65/RelA for K-Ras-induced lung tumorigenesis. Cancer Res. 70, 3537-354.   DOI
65 Zhu, L., Fukuda, S., Cordis, G., Das, D.K., and Maulik, N. (2001). Anti-apoptotic protein surviving plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett. 508, 369-374.   DOI   ScienceOn
66 Ben-Neriah, Y., and Karin, M. (2011). Inflammation meets cancer, with NF-$\kappa{B}$as the matchmaker. Nat. Immunol. 12, 715-723.   DOI   ScienceOn
67 Bonizzi, G., and Karin, M. (2004). The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.   DOI   ScienceOn
68 Kasibhatla, S., Genestier, L., and Green, D.R. (1999). Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J. Biol. Chem. 274, 987-992.   DOI   ScienceOn
69 Popivanova, B.K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., and Mukaida, N. (2008). Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118, 560-570.
70 Ngo, V.N., Davis, R.E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L.T., Dave, S., Yang, L., Powell, J., et al. (2006). A loss-offunction RNA interference screen for molecular targets in cancer. Nature 441, 106-110.   DOI   ScienceOn